Tag #Capivasertib

Showing 1 to 3 of 3 results

bbc.com
🌐 85% Global Worthiness
News related image

Wales Rolls Out Cancer Drug Doubling Survival Time

The NHS in Wales now provides capivasertib, a new breast cancer drug shown to double life expectancy for half of women with oestrogen-fueled breast cancer when combined with hormone therapy; developed by Velindre Cancer Centre and Cardiff University, it's a significant advancement offering extended ...

Progress

56% Bias Score

Good Health and Well-being
dailymail.co.uk
🌐 85% Global Worthiness
News related image

NHS Approves Capivasertib for Advanced Breast Cancer

The NHS approved capivasertib, a twice-daily pill, for HR-positive HER2-negative breast cancer with specific gene mutations, benefiting up to 3,000 women yearly by extending progression-free survival by 4.2 months; this follows extensive research and clinical trials.

Progress

36% Bias Score

Good Health and Well-being
bbc.com
🌐 85% Global Worthiness
News related image

NHS England Approves New Drug for Advanced Breast Cancer

A new drug, capivasertib, is now available on the NHS in England to treat advanced breast cancer, offering a potential benefit to 3,000 women yearly by slowing disease progression and shrinking tumors; it targets the AKT protein and was approved after successful clinical trials showing it doubled th...

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results